FDA Approves Takeda’s HyQvia for Maintenance of Chronic Inflammatory Demyelinating Polyneuropathy Posted on January 18, 2024January 18, 2024 by admin HyQvia is the only subcutaneous immune globulin infusion that can be administered once per month.
